Chinese Atherosclerosis Risk Evaluation- Phase II "CARE-II"


Phase N/A Results N/A

Summary of Purpose

Stroke is the first and the fourth leading cause of death in the United States and China, respectively. Disruption of cerebrovascular vulnerable atherosclerotic plaque is the major etiology of ischemic stroke. Therefore, early detection and treatment of vulnerable plaques occurring at the feeding arteries to brain (cerebral arteries) will be helpful for prevention of stroke. Atherosclerosis is a systemic...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 December 2013.

1 Jan 2012 4 Dec 2013 1 Jun 2014 1 Dec 2014 1 Dec 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Case-Only
  • Perspective: Cross-Sectional
  • Sampling: Probability Sample